Last reviewed · How we verify
NCT03089073
Study of Minirin Melt® in Adult Patients With Nocturia
trial testing Desmopressin in Nocturia in 835 participants. Terminated before completion.
5 October 2018
Quick facts
| Lead sponsor | Ferring Pharmaceuticals |
|---|---|
| Status | Terminated |
| Study type | OBSERVATIONAL |
| Enrollment | 835 |
| Start date | 13 July 2015 |
| Primary completion | 5 October 2018 |
| Estimated completion | 5 October 2018 |
| Sites | 1 location across South Korea |
Drugs / interventions tested
- Desmopressin (DESMOPRESSIN) — full drug profile →
Conditions studied
- Nocturia — all drugs for Nocturia →
Sponsor
Ferring Pharmaceuticals — full company profile →
Who can join
Adults 19 to 65, any sex, with Nocturia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Observation of safety and efficacy of Minirin Melt® in adult patients with nocturia
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03089073
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Desmopressin
Trials testing the same drug.
- NCT07292753 — Vitamin D Versus Desmopressin Versus Combination Therapy in Children With Primary Monosymptomatic Nocturnal Enuresis and · NA · completed
- NCT06635629 — Desmopressin Stimulation Test Performance in ACTH-Dependent Cushing Syndrome · Phase 2 · recruiting
- NCT06255366 — Analysis of the Clinical Efficacy of Intravenous Application of Hemostatic Drugs in Improving the Clarity of Vision Unde · Phase 4 · unknown
- NCT06285006 — Desmopressin Monotherapy for Monosymptomatic Nocturnal Enuresis · NA · recruiting
- NCT06185361 — Selective Serotonin Reuptake Inhibitors, Fluoxetine Versus the Standard Oral Desmopressin for Management of Mono-symptom · NA · unknown
Other recruiting trials for Nocturia
Currently open trials in the same condition.
- NCT06754189 — Safety and Performance of UCon Patch Electrode · NA · recruiting
- NCT06866834 — Examination of the Effect of Nocturia on Pelvic Floor Symptoms, Sleep Parameters and Quality of Life in Women with Urina · recruiting
- NCT06091566 — Safety and Performance of UCon Bar Electrode for the Treatment of Overactive Bladder (OAB) and Bowel Dysfunction (BD) · NA · recruiting
- NCT05874375 — UCon Treatment of Overactive Bladder (OAB) in Males · NA · recruiting
- NCT05604222 — Effect of Behavioral Sleep Intervention on Lower Urinary Tract Symptoms in Older Women · Phase 4 · recruiting
Other Ferring Pharmaceuticals trials
Trials by the same sponsor.
- NCT07152730 — A Study to Measure Pharmacokinetic (PK) Concentrations of Gonadotropin-Releasing Hormone Delivered by the OmniPod Pump · Phase 1 · withdrawn
- NCT07029451 — To Investigate REKOVELLE in Chinese Women Undergoing Assisted Reproductive Technologies: Effectiveness, Safety, and Patt · recruiting
- NCT06668493 — Low-grade UTUC Treated With Nadofaragene Firadenovec Administered to Renal Pelvis · Phase 1, PHASE2 · recruiting
- NCT06545955 — A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in · Phase 3 · recruiting
- NCT06510374 — Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Can · Phase 3 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03089073 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ferring Pharmaceuticals
- Last refreshed: 5 February 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03089073.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing